In 2024, the U.S. Drug Enforcement Administration (DEA) indicated that they intend to reclassify cannabis as being a Plan III drug. This rescheduling will figure out that cannabis has legitimate medical functions and can help open the doorway to exploration on other opportunity procedure uses.